Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus

Antiviral Research
Sandra L BixlerTravis Warren

Abstract

Favipiravir is a broad-spectrum antiviral agent that has demonstrated efficacy against Ebola virus (EBOV) in rodents. However, there are no published reports of favipiravir efficacy for filovirus infection of nonhuman primates (NHPs). Here we evaluated the pharmacokinetic profile of favipiravir in NHPs, as well as in vivo efficacy against two filoviruses, EBOV and Marburg virus (MARV). While no survival benefit was observed in two studies employing once- or twice-daily oral dosing of favipiravir during EBOV infection of NHPs, an antiviral effect was observed in terms of extended time-to-death and reduced levels of viral RNA. However, oral dosing in biosafety level-4 (BSL-4) presents logistical and technical challenges, and repeated anesthesia events may potentially worsen survival outcome in animals. For the third study of treatment of MARV infection, we therefore made use of catheters, jackets, and tethers for intravenous (IV) dosing and blood collection, which minimized the requirement for repeated anesthesia events. When MARV infection was treated with IV favipiravir, five of six animals (83%) survived infection, while all untreated NHPs succumbed. An accompanying report presents the results of favipiravir treatment of EBOV ...Continue Reading

Citations

Jul 10, 2018·The Journal of Infectious Diseases·Md N RahimXiangguo Qiu
Aug 8, 2019·Chemistry, an Asian Journal·Erik De Clercq
Nov 16, 2018·Journal of Medical Virology·Muhammad Usman MirzaMuhammad Idrees
Mar 22, 2020·CPT: Pharmacometrics & Systems Pharmacology·Vincent MadelainJérémie Guedj
Jun 2, 2020·The Journal of Infectious Diseases·Danielle P PorterTravis K Warren
Sep 24, 2020·Revista da Associação Médica Brasileira·Selçuk YaylaciOğuz Karabay
Oct 1, 2019·Annual Review of Virology·Wakako Furuyama, Andrea Marzi
Jul 30, 2020·Clinical Pharmacokinetics·Markus ZeitlingerUNKNOWN PK/PD of Anti-Infectives Study Group (EPASG) of the European Society of Clinical Microbiology, Infectious Diseases (ESCMID)
May 15, 2020·Microbiology and Molecular Biology Reviews : MMBR·Elizabeta S RistanovićAna S Gligić
Apr 17, 2019·Viruses·Egor P TchesnokovMatthias Götte
Feb 23, 2020·Virus Genes·J J BugertA Brancale
Aug 14, 2020·ILAR Journal·Steven M Niemi
Dec 11, 2020·Antiviral Chemistry & Chemotherapy·Johanna Huchting
Dec 30, 2020·Expert Review of Anti-infective Therapy·Seyed MohammadReza HashemianAli Akbar Velayati
Jan 8, 2021·PLoS Computational Biology·Guillaume LingasJérémie Guedj
Nov 17, 2020·Frontiers in Molecular Biosciences·Elena Cabezón, Ignacio Arechaga
Feb 18, 2021·Expert Opinion on Investigational Drugs·Frederick HansenMichael A Jarvis
Jul 20, 2020·Antiviral Research·Thomas R LaneSean Ekins
Apr 20, 2019·Current Opinion in Virology·Megan R Edwards, Christopher F Basler
Aug 25, 2020·American Journal of Obstetrics & Gynecology MFM·Margaux LouchetLaurent Mandelbrot
Jun 14, 2019·Antiviral Research·Nicole EspyGustavo Palacios
Aug 11, 2021·Viruses·Olivier EscaffreJason E Comer
Sep 22, 2020·European Journal of Pharmacology·Kiavash HushmandiSeyed Mohammad Nabavi
Dec 29, 2021·Expert Opinion on Drug Discovery·Steven B Bradfute

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.